EXD2: A new regulator of mitochondrial translation and potential target for cancer therapy

被引：1
|
作者：
Stracker, Travis H. [1 ]
机构：
[1] BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2018年 / 5卷 / 03期
关键词：
EXD2; mitochondria; metabolic reprogramming; metformin; cancer metabolism; translation; glutamine; Biology of malignant cells; Cancer stem cells; Mode of action of anticancer agents; Tumor metabolism;
D O I：
10.1080/23723556.2018.1445943
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In recent work we identified Exonuclease 3'-5' domain-containing protein 2 (EXD2) as an RNase required for efficient mitochondrial translation. Here I describe in brief the cellular phenotypes caused by EXD2 deficiency and make the case that EXD2 inhibitors could be valuable agents for cancer therapy.
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Regucalcin Is a Potential Regulator in Human Cancer: Aiming to Expand into Cancer Therapy
    Yamaguchi, Masayoshi
    CANCERS, 2023, 15 (22)
  • [42] Sorcin a Potential Molecular Target for Cancer Therapy
    Shabnam, Bano
    Padmavathi, Ganesan
    Banik, Kishore
    Girisa, Sosmitha
    Monisha, Javadi
    Sethi, Gautam
    Fan, Lu
    Wang, Lingzhi
    Mao, Xinliang
    Kunnumakkara, Ajaikumar B.
    TRANSLATIONAL ONCOLOGY, 2018, 11 (06): : 1379 - 1389
  • [43] Invadopodia: A potential target for pancreatic cancer therapy
    Luo, Yan
    Hu, Jisheng
    Liu, Yong
    Li, Le
    Li, Yilong
    Sun, Bei
    Kong, Rui
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 159
  • [44] iASPP, A potential drug target in cancer therapy
    Gillotin, Sebastien
    LEUKEMIA RESEARCH, 2009, 33 (09) : 1175 - 1177
  • [45] The urokinase receptor as a potential target in cancer therapy
    Romer, J
    Nielsen, BS
    Ploug, M
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (19) : 2359 - 2376
  • [46] The centrosome as potential target for cancer therapy and prevention
    Korzeniewski, Nina
    Hohenfellner, Markus
    Duensing, Stefan
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (01) : 43 - 52
  • [47] Angiogenesis as a potential target of pharmaconutrients in cancer therapy
    Granci, Virginie
    Dupertuis, Yves M.
    Pichard, Claude
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2010, 13 (04): : 417 - 422
  • [48] Lysyl oxidase: A potential target for cancer therapy
    Siddikuzzaman
    Berlin Grace V.M.
    Guruvayoorappan C.
    Inflammopharmacology, 2011, 19 (3) : 117 - 129
  • [49] Talin: A Potential Drug Target for Cancer Therapy
    Malla, Rama Rao
    Vempati, Rahul Kumar
    CURRENT DRUG METABOLISM, 2020, 21 (01) : 25 - 32
  • [50] The Proline Cycle As a Potential Cancer Therapy Target
    Tanner, John J.
    Fendt, Sarah-Maria
    Becker, Donald F.
    BIOCHEMISTRY, 2018, 57 (25) : 3433 - 3444
12345